Z17.32

Billable

Human epidermal growth factor receptor 2 negative status

Human epidermal growth factor receptor 2 negative status

Status

Billable / Specific

Block

Z17-Z17

Parent Code

Z17.3

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • HER2-

Code First

The underlying condition must be sequenced before this code

  • malignant neoplasm, such as:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of ovary (C56.-)

Also Known As / Clinical Terms

Frequently Asked Questions

What is the ICD-10 code for human epidermal growth factor receptor 2 negative status?

The ICD-10-CM code for human epidermal growth factor receptor 2 negative status is Z17.32. The full clinical description is "Human epidermal growth factor receptor 2 negative status". Z17.32 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code Z17.32 mean?

ICD-10-CM code Z17.32 represents "Human epidermal growth factor receptor 2 negative status". It is classified under Chapter 22: Factors Influencing Health Status and Contact With Health Services and is a billable/specific code that can be used on a claim.

Is Z17.32 a billable code?

Yes, Z17.32 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is Z17.32 in?

Z17.32 is in Chapter 22: Factors Influencing Health Status and Contact With Health Services (codes Z00-Z99).

What are the UMLS CUIs for Z17.32?

Z17.32 is linked to 1 UMLS Concept Unique Identifier: C5926807. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.